Clinical Trial Update: MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 Diabetes [Phase 4]

View source ↗

Summary

MASTERMIND is a Phase 4 study investigating why individuals with Type 2 diabetes mellitus respond differently to therapies; the update notes completion of the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Royal Devon and Exeter NHS Foundation Trust | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED